We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
(-2.6%)
Cap. Flow
-$4.15B
Cap. Flow
% of AUM
-9.34%
Top 10 Holdings %
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$309M |
| 2 |
ExxonMobil
XOM
|
+$302M |
| 3 |
Amazon
AMZN
|
+$291M |
| 4 |
Citigroup
C
|
+$253M |
| 5 |
Shopify
SHOP
|
+$238M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$383M |
| 2 |
Johnson & Johnson
JNJ
|
+$312M |
| 3 |
JPMorgan Chase
JPM
|
+$285M |
| 4 |
AT&T
T
|
+$191M |
| 5 |
Dollar General
DG
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.63% |
| 2 | Financials | 15.61% |
| 3 | Technology | 14.28% |
| 4 | Consumer Discretionary | 13.21% |
| 5 | Industrials | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Insulet
PODD
$11.3B
| $38.7M | 0.09% |
131,395
+42,504
| +48% | +$11.7M |
|
252
Paycom
PAYC
$6.78B
| $38.6M | 0.09% |
124,512
-134,596
| -52% | -$43.4M |
|
253
KBR
KBR
$4.68B
| $38.6M | 0.09% |
730,678
-433,300
| -37% | -$21.6M |
|
254
Tidewater
TDW
$3.91B
| $38.4M | 0.09% |
1,041,359
-315,203
| -23% | -$9.59M |
|
|
UNVR
255
DELISTED
Univar Solutions Inc.
UNVR
| $38.2M | 0.09% |
1,200,768
+358,173
| +43% | +$10.3M |
|
|
APGB
256
DELISTED
Apollo Strategic Growth Capital II
APGB
| $38M | 0.09% |
3,797,333
| – | – |
|
257
L3Harris
LHX
$55.9B
| $37.8M | 0.08% |
181,367
+102,622
| +130% | +$23.1M |
|
258
MakeMyTrip
MMYT
$4.67B
| $37.4M | 0.08% |
1,355,594
-52,714
| -4% | -$1.52M |
|
259
PayPal
PYPL
$49.5B
| $37.2M | 0.08% |
522,958
+46,001
| +10% | +$3.68M |
|
260
Cal-Maine
CALM
$4.28B
| $37.1M | 0.08% |
682,145
-54,830
| -7% | -$3.17M |
|
261
Sensata Technologies
ST
$6.65B
| $36.9M | 0.08% |
912,819
-931,194
| -50% | -$38.8M |
|
262
iShares Expanded Tech-Software Sector ETF
IGV
$13B
| $36.8M | 0.08% |
719,725
+484,955
| +207% | +$25.1M |
|
263
Analog Devices
ADI
$181B
| $36.8M | 0.08% |
224,204
+88,462
| +65% | +$13.8M |
|
264
Advanced Drainage Systems
WMS
$10.9B
| $36.8M | 0.08% |
448,387
+322,705
| +257% | +$32.7M |
|
265
CALL
Costco
COST
$415B
| $36.7M | 0.08% |
80,400
+37,800
| +89% | +$18.5M |
|
266
Charter Communications
CHTR
$14.7B
| $36.6M | 0.08% |
108,011
+68,751
| +175% | +$24.2M |
|
267
Corebridge Financial
CRBG
$14.1B
| $36.5M | 0.08% |
1,820,406
-473,245
| -21% | -$10M |
|
268
Albertsons Companies
ACI
$5.4B
| $36.5M | 0.08% |
1,759,814
-1,644,283
| -48% | -$36.1M |
|
|
OPTU
269
Optimum Communications Inc
OPTU
$316M
| $36.5M | 0.08% |
7,926,226
+5,284,411
| +200% | +$26M |
|
270
Electronic Arts
EA
$52.4B
| $36.3M | 0.08% |
297,339
-238,503
| -45% | -$30M |
|
271
Darden Restaurants
DRI
$22.5B
| $36.2M | 0.08% |
+261,479
| New | +$36.5M |
|
272
Oracle
ORCL
$331B
| $36M | 0.08% |
440,653
+225,843
| +105% | +$17.2M |
|
273
Marvell Technology
MRVL
$174B
| $35.9M | 0.08% |
970,489
-272,634
| -22% | -$11.1M |
|
|
SAGE
274
DELISTED
Sage Therapeutics
SAGE
| $35.6M | 0.08% |
932,923
-69,737
| -7% | -$2.66M |
|
|
CPE
275
DELISTED
Callon Petroleum Company
CPE
| $35.5M | 0.08% |
958,436
+207,514
| +28% | +$8.52M |
|
Similar funds
Marshall Wace's Q4 2022 Portfolio in Review
As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.
- Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
- Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
- Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
- Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
- Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
- Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.
Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.